Editorial: Biomarkers to evaluate rare diseases

نویسندگان

چکیده

EDITORIAL article Front. Mol. Med, 26 June 2023Sec. Molecular Pathology Volume 3 - 2023 | https://doi.org/10.3389/fmmed.2023.1237089

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Orphanet Journal of Rare Diseases: Launch Editorial

We wish to express our gratitude to the many colleagues who have agreed to serve as section editors for their specialties. To a considerable extent, the quality of the journal will depend on their commitment. The journal's editorial office is established at the Orphanet headquarters in Paris and supported by several major institutions including INSERM, the French Ministry of Health and the Euro...

متن کامل

Editorial Biomarkers in Clinical Trials

In contemporary cardiovascular practice, the most common and useful applications of biomarkers focus on disease diagnosis, with troponins for myocardial infarction and natriuretic peptides for heart failure representing the most notable examples. Identification of additional cardiovascular diagnostic markers has proved challenging, however, because high quality studies for diagnostic indication...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Frontiers in Molecular Medicine

سال: 2023

ISSN: ['2674-0095']

DOI: https://doi.org/10.3389/fmmed.2023.1237089